EEMS:NYE-iShares MSCI Emerging Markets Small-Cap ETF (USD)

ETF | Diversified Emerging Mkts |

Last Closing

USD 63.44

Change

+0.14 (+0.22)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Diversified Emerging Mkts

Symbol Name Price(Change) Market Cap
IEMG iShares Core MSCI Emerging Mar..

+0.52 (+0.90%)

USD 85.12B
VWO Vanguard FTSE Emerging Markets..

+0.59 (+1.22%)

USD 82.22B
EEM iShares MSCI Emerging Markets ..

+0.43 (+0.92%)

USD 19.16B
SPEM SPDR® Portfolio Emerging Mark..

+0.44 (+1.05%)

USD 10.10B
FNDE Schwab Fundamental Emerging Ma..

+0.43 (+1.30%)

USD 6.74B
XCEM Columbia EM Core ex-China ETF

+0.17 (+0.53%)

USD 1.28B
GEM Goldman Sachs ActiveBeta® Eme..

+0.37 (+1.05%)

USD 0.99B
JHEM John Hancock Multifactor Emerg..

+0.24 (+0.85%)

USD 0.71B
EDIV SPDR® S&P Emerging Markets Di..

N/A

USD 0.49B
EMQQ EMQQ The Emerging Markets Inte..

+0.82 (+2.02%)

USD 0.41B

ETFs Containing EEMS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diversified Emerging Mkts) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.74% 28% F 55% F
Dividend Return 0.44% 10% F 6% D-
Total Return 10.18% 23% F 47% F
Trailing 12 Months  
Capital Gain 16.70% 21% F 47% F
Dividend Return 2.72% 42% F 38% F
Total Return 19.42% 8% B- 44% F
Trailing 5 Years  
Capital Gain 49.27% 100% F 69% C-
Dividend Return 8.05% 28% F 25% F
Total Return 57.32% 97% N/A 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 12.19% N/A N/A 73% C
Dividend Return 13.69% N/A N/A 71% C-
Total Return 1.50% N/A N/A 35% F
Risk Return Profile  
Volatility (Standard Deviation) 26.04% N/A N/A 40% F
Risk Adjusted Return 52.59% N/A N/A 69% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike